Argenx
ARGX
$742.57
Share price
-0.92%
Change (1 day)
42.37%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
EPS for Argenx (ARGX)
EPS in 2023 (TTM): -$5.63
According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.62. In 2022 the company made an earnings per share (EPS) of -$17.71.
EPS history for Argenx from 2022 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.63 | -68.23% |
| 2022 | -$17.71 |